OPUVIZ, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen's second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency IN ...
“It is not in the best interests of the owners or the directors, it is the best interests of our fans ... grappled with a fractured playing group and a divide between coach and board. Captain Daly ...